Peter Attia· MD
um you know, biomarkers are so important. And when I think about cardiovascular disease, uh and even though it's the leading cause of death, why I tell my patients it's the one you need to be least afraid of if you're willing to be proactive in management. And it comes down to the fact that we just have such a clear understanding of how the disease works and we have exceptional biomarkers, right? So we we can measure the things that are causing the disease. We can measure inflammation. We can measure apo. We can measure VLDLDL cholesterol, LP little A. We also we can measure blood pressure. We can measure metabolic health. And we know how to address those things. And we know that when we address those things, we can measure whether what we're doing is working. Okay, so problem solved basically. Um, when it comes to the immune system, let's we're going to talk about Manic and Clickstein in a moment. But as we saw from their paper 10 years ago, um, they gave a rapamy analog to people uh people who were in their 60s, vaccinated them and demonstrated that oh boy, you got a much better immune response. Okay, they were able to demonstrate that using laboratory techniques. I'm sure they used flowcytometry or something like that to measure it.